Filing Flows › Orthopediatrics (KIDS) › Q2 2026 › vs Q2 2025
Orthopediatrics (KIDS) Q2 2026 vs Q2 2025 (year over year)
Orthopediatrics's revenue rose $9.4M (+15%) from $61.1M in Q2 2025 to $70.5M in Q2 2026. The biggest changes: Trauma and deformity +$11.0M (+26%); Scoliosis −$1.6M (-9%); Sports medicine/other +$95K (+10%).
Orthopediatrics, Q2 2026: revenue $70.5M (+15% year over year), operating margin -5.8%, net loss $7.2M, operating cash flow $928K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Trauma and deformity | $52.6M | $41.7M | $11.0M | +26% |
| Scoliosis | $16.9M | $18.5M | −$1.6M | -9% |
| Sports medicine/other | $1.0M | $905K | $95K | +10% |
| Revenue | $70.5M | $61.1M | $9.4M | +15% |
| Net loss | $7.2M | $7.1M | $50K | +0.7% |
| Costs & expenses | $77.7M | $71.8M | $5.9M | +8% |
| Operating costs | $74.6M | $71.7M | $2.8M | +4% |
| Interest & other, net | $2.9M | −$3.6M | $6.5M | — |
| Income tax | $234K | $49K | $185K | +378% |
| Cost of revenue | $18.1M | $17.1M | $1.1M | +6% |
| Research & development | $2.3M | $2.2M | $166K | +8% |
| Sales & marketing | $21.3M | $19.1M | $2.2M | +11% |
| General & admin | $32.8M | $30.4M | $2.4M | +8% |
| Operating cash sources | $9.9M | $10.4M | −$525K | -5% |
| Depreciation & amortization | $5.7M | $5.2M | $536K | +10% |
| Share-based compensation | $4.2M | $5.3M | −$1.1M | -20% |
| Net loss absorbed | $7.2M | $7.1M | $50K | +0.7% |
| Working capital & other | $1.8M | $13.8M | −$12.0M | -87% |
| Operating cash flow | $928K | −$10.5M | $11.4M | — |
| Capital expenditures | $4.0M | $3.4M | $600K | +17% |
| Negative free cash flow (OCF − capex) | $3.1M | $13.9M | −$10.8M | -78% |
Questions
How much did Orthopediatrics's revenue grow year over year in Q2 2026?
Orthopediatrics's revenue rose $9.4M (+15%) from $61.1M in Q2 2025 to $70.5M in Q2 2026.
What drove Orthopediatrics's revenue change in Q2 2026?
Trauma and deformity +$11.0M (+26%); Scoliosis −$1.6M (-9%); Sports medicine/other +$95K (+10%).